OSPEDALE PEDIATRICO BAMBINO GESU - Italy 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:> 1000
Total Number of Projects:600-700
2018
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:400-500
Total Number of Projects:68
Total Project Funding:300-400
Partner Constancy:54
Project Leadership Index:65
Diversity Index:40
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Total Project Funding:400-500
Networking Rank (Reputation):500-600
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Total Project Funding:200-300
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 44
As coordinator: 1
As participant: 42
Sole participant: 1
Coordinator / Participant Ratio: 0.02*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 10.325.547 341.754 3
2021 0 33.830.652 2.102.641 4
2020 183.473 51.423.248 1.339.973 1 6
2018 0 97.826.311 5.943.247 5
2017 0 39.521.414 1.445.414 5
2016 0 3.456.189 101.250 1
2015 0 11.599.675 908.788 3
2014 0 5.993.000 391.758 1
2013 11.869.000 31.585.050 1.546.438 1 5
2012 0 5.946.262 991.044 1
2011 0 18.997.763 1.590.620 3
2010 0 30.321.869 1.426.572 5

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE16
UNIVERSITY COLLEGE LONDON14
TARTU ULIKOOL10
KATHOLIEKE UNIVERSITEIT LEUVEN9
KAROLINSKA INSTITUTE8
SERVICIO MADRILENO DE SALUD8
STICHTING KATHOLIEKE UNIVERSITEIT8
CHARITE UNIVERSITAETSMEDIZIN BERLIN7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS6
NOVARTIS PHARMA6
THE UNIVERSITY OF LIVERPOOL6
UNIVERSITAET ULM6
UNIVERSITY OF NEWCASTLE UPON TYNE6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
UNIVERSITY OF HELSINKI5
BAYER4
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
JANSSEN PHARMACEUTICA NV4
LYNKEUS4
MAAT FRANCE SARL4
PFIZER LIMITED4
REGION HOVEDSTADEN4
STICHTING VUMC4
UNIVERSITAET ZUERICH4
UNIVERSITY OF LEICESTER4
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM3
CELGENE MANAGEMENT SARL3
CHARLES UNIVERSITY PRAGUE3
DEUTSCHES HERZZENTRUM BERLIN3
ERASMUS UNIVERSITEIT ROTTERDAM3
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION3
EUROPEAN HEMATOLOGY ASSOCIATION3
F HOFFMANNLA ROCHE3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR3
FONDAZIONE PENTAFOR THE TREATMENT AND CARE OF CHILDREN WITH HIVONLUS3
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON3
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT3
INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA3
ISTITUTO GIANNINA GASLINI3
KING'S COLLEGE LONDON3
MEDIZINISCHE HOCHSCHULE HANNOVER3
MEDIZINISCHE UNIVERSITAET WIEN3
MEDIZINISCHE UNIVERSITAT GRAZ3
NOVO NORDISK3
OSLO UNIVERSITETSSYKEHUS HF3
OSPEDALE SAN RAFFAELE3
PHILIPPS UNIVERSITAET MARBURG3
SANOFIAVENTIS3
ST GEORGE'S HOSPITAL MEDICAL SCHOOL3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITEIT ANTWERPEN3
UNIVERZA V LJUBLJANI3
VIB VZW3
ABBVIE INC2
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
ARISTOTLE UNIVERSITY OF THESSALONIKI2
ATOS ORIGIN INTEGRATION SAS2
ATOS SPAIN2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE2
CENTRE DE REGULACIO GENOMICA2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONCENTRIS RESEARCH MANAGEMENT2
CONSIGLIO NAZIONALE DELLE RICERCHE2
EATRIS ERIC2
EUROPEAN FOUNDATION FOR THE CARE OF NEWBORN INFANTS2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FONDAZIONE PENTA FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES ONLUS2
FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS2
FUNDACIO EURECAT2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU2
FUNDACIO SANT JOAN DE DEU2
FUNDACION HOSPITAL LA FE2
GENOME RESEARCH2
GENOMIC INVESTMENTS BV2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
HACETTEPE UNIVERSITESI2
HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE2
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE2
HOSPITAL SANT JOAN DE DEU2

Constancy:

Total number of partners: 826
Partner loyalty:
Frequent Partner: (> 2 projects): 273
Rare Partner: 553
Frequent / Rare Partner Ratio: 0.49

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Cyber securitY tooLbox for COnnected MEdical Devices CYLCOMEDparticipant3.489.62511
2022-09-01Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival EChiLiBRiSTparticipant6.535.67212
2022-03-01LEAF: heaL thE plAnet's Future LEAFparticipant300.2507
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56937
2021-01-01Training experts in antigen processing to deliver new drug prototypes for cancer and autoimmune diseases CAPSTONEparticipant3.968.73610
2021-01-01AI Accelerator – A Smart Hospital Care Pathway Engine AICCELERATEparticipant9.195.16217
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-11-01PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis PARENTparticipant3.835.85311
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00037
2020-05-01Investigating the functional impact of neurodegeneration-causing rare variants in the teleost model zebrafish INNERVATEcoordinator183.4731
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05541
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69430
2020-01-01Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis DIAMONDSparticipant22.582.02132
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00047
2018-05-01Immunome project consortium for AutoInflammatory Disorders ImmunAIDparticipant15.835.85125
2018-01-01Infradev - European Paediatric Translational Research Infrastructure ID-EPTRIparticipant3.000.00029
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2018-01-01Transfer of multivirus-specific T-cells following transplantation TRACEparticipant6.000.0008
2017-05-01Improving the guidelines for Informed Consent, including vulnerable populations, under a gender perspective I-CONSENTparticipant3.077.1989
2017-04-01FrontierResearchCompentences@CNAP FRESCOatCNAPparticipant627.84015
2017-01-01EURopean Endeavour for Chimeric Antigen Receptor Therapies EURE-CARTparticipant5.903.1469
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01RECAP preterm: Research on European Children and Adults born Preterm RECAP pretermparticipant9.713.23021
2016-11-01My Health - My Data MH-MDparticipant3.456.18917
2015-09-01Screening to improve Health In very Preterm infantS in Europe SHIPSparticipant2.993.17514
2015-07-01Visual Privacy Management in User Centric Open Environments VisiOnparticipant2.748.91313
2015-01-01Restoring tissue regeneration in patients with visceral Graft versus Host Disease. RETHRIMparticipant5.857.58811
2014-02-01Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months NEOVANCparticipant5.993.00012
2013-12-01Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit CLOSEDparticipant5.997.40510
2013-11-01Aggression subtyping for improved insight and treatment innovation in psychiatric disorders AGGRESSOTYPEparticipant6.000.00023
2013-11-01Data-as-a-Service platform for Healthy Lifestyle and preventive medicine DAPHNEparticipant3.484.99910
2013-10-01"Development and Epilepsy - Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy" DESIREparticipant11.995.64625
2013-10-01Proof of Concept of Model-based Cardiovascular Prediction CARDIOPROOFparticipant4.107.00010
2013-03-01Model-Driven European Paediatric Digital Repository MD PAEDIGREEcoordinator11.869.00022
2012-07-01First Targeted Therapy to FIGHT Hemophagocytic Lymphohistiocytosis (HLH): A novel approach to HLH FIGHT-HLHparticipant5.946.2626
2011-10-01International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research INTREALLparticipant5.998.05525
2011-01-01Global Research in Paediatrics GRiPparticipant10.000.00023
2011-01-01Effective Perinatal Intensive Care in Europe: translating knowledge into evidence based practice EPICEparticipant2.999.70813
2010-11-01Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency CELL-PIDparticipant11.887.73520
2010-05-01Paediatric European Risperidone Studies PERSparticipant5.600.00021
2010-03-01Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials LeukoTreatparticipant5.978.12625
2010-01-01Grid-Enabled Platform for Simulations in Paediatric Cardiology – Toward the Personalized Virtual Child Heart Sim-e-Childparticipant956.0089
2010-01-01European multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis NEOMEROparticipant5.900.00012

Alias institution names:

  • OSPEDALE PEDIATRICO BAMBINO GESU